Improvement of thyroid eye disease following treatment with the cyclooxygenase-2 selective inhibitor celecoxib.
Kuriyan
Ajay E
AE
Phipps
Richard P
RP
O'Loughlin
Charles W
CW
Feldon
Steven E
SE
D000368:Aged; D000068579:Celecoxib; D003118:Color Perception / Q000187:drug effects; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use*; D005260:Female; D049970:Graves Ophthalmopathy / Q000188:drug therapy*; D006801:Humans; D011241:Prednisone / Q000009:adverse effects; D011720:Pyrazoles / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*; D014792:Visual Acuity / Q000187:drug effects
D052246:Cyclooxygenase 2 Inhibitors; D011720:Pyrazoles; D013449:Sulfonamides; D000068579:Celecoxib; D011241:Prednisone